33.71
price down icon0.13%   -0.044
pre-market  プレマーケット:  32.20   -1.506   -4.47%
loading
前日終値:
$33.75
開ける:
$33.39
24時間の取引高:
2.23M
Relative Volume:
1.26
時価総額:
$3.24B
収益:
$47.30M
当期純損益:
$-225.97M
株価収益率:
-14.34
EPS:
-2.35
ネットキャッシュフロー:
$-188.86M
1週間 パフォーマンス:
+5.50%
1か月 パフォーマンス:
-5.03%
6か月 パフォーマンス:
-0.31%
1年 パフォーマンス:
+290.12%
1日の値動き範囲:
Value
$33.00
$34.31
1週間の範囲:
Value
$29.78
$34.50
52週間の値動き範囲:
Value
$6.76
$46.98

Scholar Rock Holding Corp Stock (SRRK) Company Profile

Name
名前
Scholar Rock Holding Corp
Name
セクター
Healthcare (1150)
Name
電話
857-259-3860
Name
住所
301 BINNEY STREET, CAMBRIDGE, MA
Name
職員
196
Name
Twitter
@ScholarRock
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
SRRK's Discussions on Twitter

SRRK を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SRRK
Scholar Rock Holding Corp
33.71 3.24B 47.30M -225.97M -188.86M -2.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
376.62 97.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
576.98 60.19B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
458.37 59.56B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
729.76 44.94B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
329.84 36.14B 3.81B -644.79M -669.77M -6.24

Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-17 開始されました Barclays Overweight
2025-09-15 開始されました Leerink Partners Outperform
2025-08-21 再開されました Jefferies Buy
2025-07-30 再開されました Raymond James Strong Buy
2025-07-17 開始されました Cantor Fitzgerald Overweight
2024-11-26 繰り返されました H.C. Wainwright Buy
2024-10-07 繰り返されました H.C. Wainwright Buy
2024-03-28 開始されました Raymond James Strong Buy
2023-10-25 アップグレード Jefferies Hold → Buy
2023-04-03 再開されました Piper Sandler Overweight
2022-09-19 再開されました H.C. Wainwright Buy
2022-07-12 開始されました Truist Buy
2022-03-23 開始されました H.C. Wainwright Buy
2021-12-22 ダウングレード Jefferies Buy → Hold
2021-11-19 開始されました Piper Sandler Overweight
2021-04-26 再開されました Credit Suisse Outperform
2021-01-11 開始されました Credit Suisse Outperform
2021-01-06 開始されました JP Morgan Overweight
2020-03-12 開始されました Robert W. Baird Outperform
すべてを表示

Scholar Rock Holding Corp (SRRK) 最新ニュース

pulisher
Sep 24, 2025

Scholar Rock (NASDAQ:SRRK) Insider Sells $102,836.51 in Stock - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

SRRK: Piper Sandler Maintains Rating but Lowers Price Target | S - GuruFocus

Sep 24, 2025
pulisher
Sep 24, 2025

Another Catalent Indiana delay: Scholar Rock gets CRL for apitegromab - BioWorld MedTech

Sep 24, 2025
pulisher
Sep 24, 2025

SRRK: Barclays Maintains 'Overweight' Rating, Lowers Price Targe - GuruFocus

Sep 24, 2025
pulisher
Sep 24, 2025

Piper Sandler lowers Scholar Rock stock price target on FDA rejection - Investing.com UK

Sep 24, 2025
pulisher
Sep 24, 2025

Scholar Rock (NASDAQ:SRRK) Price Target Lowered to $44.00 at Barclays - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

Scholar Rock stock price target lowered to $44 at H.C. Wainwright on FDA delay - Investing.com

Sep 24, 2025
pulisher
Sep 24, 2025

Leerink Partners lowers Scholar Rock stock price target to $48 on CRL delay - Investing.com

Sep 24, 2025
pulisher
Sep 23, 2025

Voya Investment Management LLC Cuts Stock Holdings in Scholar Rock Holding Corporation $SRRK - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

FDA issues complete response letter for Scholar Rock’s SMA drug By Investing.com - Investing.com South Africa

Sep 23, 2025
pulisher
Sep 23, 2025

Scholar Rock (NASDAQ:SRRK) Shares Gap Down Following Analyst Downgrade - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

SRRK: Analyst Maintains Rating but Lowers Price Target to $44 | - GuruFocus

Sep 23, 2025
pulisher
Sep 23, 2025

Scholar Rock's Spinal Muscular Atrophy Drug Faces FDA Delay Over Catalent Indiana Inspection - Benzinga

Sep 23, 2025
pulisher
Sep 23, 2025

Scholar Rock (NASDAQ:SRRK) Price Target Cut to $44.00 by Analysts at HC Wainwright - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Another Catalent delay: Scholar Rock gets CRL for apitegromab - BioWorld MedTech

Sep 23, 2025
pulisher
Sep 23, 2025

Scholar Rock's Apitegromab Approval Still Likely Despite Delay, Wedbush Says - MarketScreener

Sep 23, 2025
pulisher
Sep 23, 2025

Scholar Rock In Spotlight After FDA Refuses To Approve Muscular Atrophy Treatment Over Third-Party Manufacturing Facility Issues - Stocktwits

Sep 23, 2025
pulisher
Sep 23, 2025

Scholar Rock, A Top 10% Stock, Dives After Catalent Issues Hamper SMA Drug - inkl

Sep 23, 2025
pulisher
Sep 23, 2025

US FDA declines to approve Scholar Rock's muscle weakness drug; shares fall - Reuters

Sep 23, 2025
pulisher
Sep 23, 2025

FDA Rejection Sends Scholar Rock (SRRK) Shares Plummeting - GuruFocus

Sep 23, 2025
pulisher
Sep 23, 2025

Firefly Aerospace Posts Q2 Results, Joins Scholar Rock And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Sep 23, 2025
pulisher
Sep 23, 2025

Scholar Rock Faces FDA Setback on SMA Drug Due to Manufacturing Site Issues - MarketScreener

Sep 23, 2025
pulisher
Sep 23, 2025

Scholar Rock stock falls after FDA issues response letter for SMA drug - Investing.com Nigeria

Sep 23, 2025
pulisher
Sep 23, 2025

FDA issues complete response letter for Scholar Rock’s SMA drug - Investing.com

Sep 23, 2025
pulisher
Sep 23, 2025

US FDA declines to approve Scholar Rock's muscle weakness drug - MarketScreener

Sep 23, 2025
pulisher
Sep 23, 2025

FDA Delays First-Ever Muscle-Targeted SMA Treatment: Scholar Rock's Apitegromab Hits Manufacturing Hurdle - Stock Titan

Sep 23, 2025
pulisher
Sep 23, 2025

Scholar Rock SMA drug rejected by FDA over manufacturing concerns - Yahoo Finance

Sep 23, 2025
pulisher
Sep 22, 2025

Scholar Rock (NASDAQ:SRRK) Now Covered by Barclays - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Scholar Rock (NASDAQ:SRRK) Shares Up 9%What's Next? - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Should you wait for a breakout in Scholar Rock Holding CorporationPortfolio Performance Summary & Expert Verified Movement Alerts - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Is Scholar Rock Holding Corporation a candidate for recovery playEarnings Risk Summary & High Accuracy Buy Signal Tips - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Scholar Rock (NASDAQ:SRRK) Coverage Initiated at Barclays - MarketBeat

Sep 22, 2025
pulisher
Sep 21, 2025

Can machine learning forecast Scholar Rock Holding Corporation recoveryQuarterly Performance Summary & Risk Adjusted Swing Trade Ideas - newser.com

Sep 21, 2025
pulisher
Sep 21, 2025

Insider Selling: Scholar Rock (NASDAQ:SRRK) Director Sells 1,006 Shares of Stock - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

Insider Selling: Scholar Rock (NASDAQ:SRRK) Insider Sells 3,178 Shares of Stock - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

Leerink Partnrs Forecasts Scholar Rock Q3 Earnings - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

Full technical analysis of Scholar Rock Holding Corporation stockTrade Risk Assessment & Free Daily Entry Point Trade Alerts - newser.com

Sep 21, 2025
pulisher
Sep 21, 2025

Scholar Rock (NASDAQ:SRRK) Trading Down 5%Here's Why - MarketBeat

Sep 21, 2025
pulisher
Sep 21, 2025

What to expect from Scholar Rock Holding Corporation in the next 30 daysJuly 2025 Trends & Free Weekly Chart Analysis and Trade Guides - newser.com

Sep 21, 2025
pulisher
Sep 21, 2025

Intech Investment Management LLC Purchases 21,483 Shares of Scholar Rock Holding Corporation $SRRK - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

History Review: Is Scholar Rock Holding Corporation stock a falling knife or bargain buy2025 Short Interest & Real-Time Price Movement Reports - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Voya Investment Management LLC Cuts Position in Scholar Rock Holding Corporation $SRRK - Defense World

Sep 20, 2025
pulisher
Sep 20, 2025

Scholar Rock (NASDAQ:SRRK) Upgraded to "Strong-Buy" at Leerink Partnrs - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Published on: 2025-09-19 23:11:54 - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Will Scholar Rock Holding Corporation benefit from macro trendsQuarterly Market Review & Community Supported Trade Ideas - newser.com

Sep 20, 2025
pulisher
Sep 19, 2025

Scholar Rock shares close 6% higher after Leerink initiates at outperform - MSN

Sep 19, 2025
pulisher
Sep 19, 2025

What machine learning models say about Scholar Rock Holding Corporation2025 Key Highlights & Detailed Earnings Play Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Long term hold vs stop loss in Scholar Rock Holding CorporationWall Street Watch & High Accuracy Swing Entry Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

How moving averages guide Scholar Rock Holding Corporation tradingJuly 2025 Trends & Fast Gaining Stock Strategy Reports - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Ideas Watch: Can Scholar Rock Holding Corporation disrupt its industry2025 Historical Comparison & Daily Volume Surge Trade Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Chart based exit strategy for Scholar Rock Holding Corporation2025 Volatility Report & Growth-Oriented Investment Plans - newser.com

Sep 19, 2025

Scholar Rock Holding Corp (SRRK) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$35.77
price down icon 1.30%
$84.16
price down icon 0.45%
$29.45
price up icon 2.51%
$99.75
price up icon 1.51%
$141.00
price down icon 3.01%
biotechnology ONC
$329.84
price up icon 0.23%
大文字化:     |  ボリューム (24 時間):